UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1 MW, 140 GHz, CW gyrotron for Wendelstein 7-X

25th International Conference on Infrared and Millimeter Waves (Cat. No.00EX442), 2000, p.15-16

2000

Volltextzugriff (PDF)

10‐year follow‐up after interferon‐α therapy for chronic hepatitis C

Hepatology (Baltimore, Md.), 1998-10, Vol.28 (4), p.1121-1127

1998

Volltextzugriff (PDF)

1037 POSTER The Prolyl-3-hydroxylases (P3H) and P3H-related Genes CRTAP and SC65 Are Novel Transcriptionally Silenced Genes in Burkitt's Lymphoma

European journal of cancer (1990), 2011, Vol.47, p.S107-S107

2011

Volltextzugriff (PDF)

1144P Clinical outcomes of NSCLC patients (pts) who had brain-only metastasis at time of stage IV diagnosis, by presence versus absence of EGFR/ALK mutations

Annals of oncology, 2022-09, Vol.33, p.S1073

2022

Volltextzugriff (PDF)

1217P Breathomics eNose technology as a non-invasive, inexpensive, point-of-care predictive test to detect early stage lung cancer in never or former light smokers

Annals of oncology, 2020-09, Vol.31, p.S795-S795

2020

Volltextzugriff (PDF)

1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

123MO BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer

Annals of oncology, 2021-09, Vol.32, p.S411-S412

2021

Volltextzugriff (PDF)

1243P Cumulative incidence and metastatic patterns of relapsed vs de novo stage IV non-small cell lung cancer (NSCLC) characterized by histology and EGFR status

Annals of oncology, 2021-09, Vol.32, p.S979-S980

2021

Volltextzugriff (PDF)

1350P Characteristics, treatment patterns and outcome of non-small cell lung cancer (NSCLC) patients presenting with brain-only metastatic disease

Annals of oncology, 2021-09, Vol.32, p.S1027-S1027

2021

Volltextzugriff (PDF)

1356P Cumulative incidence and baseline imaging patterns of brain metastases in advanced EGFR and ALK positive non-small cell lung cancer (NSCLC)

Annals of oncology, 2021-09, Vol.32, p.S1028-S1029

2021

Volltextzugriff (PDF)

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

Annals of oncology, 2016-12, Vol.27, p.ix40-ix40

2016

Volltextzugriff (PDF)

140 GHz, 1 MW, CW gyrotron for fusion plasma heating

Third IEEE International Vacuum Electronics Conference (IEEE Cat. No.02EX524), 2002, p.330-331

2002

Volltextzugriff (PDF)

140 GHz high-power gyrotron development for the stellarator W7-X

Fusion engineering and design, 2005-11, Vol.74 (1), p.217-221

2005

Volltextzugriff (PDF)

140GHz high-power gyrotron development for the stellarator W7-X

Fusion engineering and design, 2005-11, Vol.74 (1-4), p.217-221

2005

Volltextzugriff (PDF)

141P Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple negative breast cancer

Annals of oncology, 2020-05, Vol.31, p.S65-S66

2020

Volltextzugriff (PDF)

164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (TNBC): Results from KEYNOTE-355

Annals of oncology, 2022-05, Vol.33, p.S197-S198

2022

Volltextzugriff (PDF)

1675P - Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain

Annals of oncology, 2012-09, Vol.23, p.ix537-ix537

2012

Volltextzugriff (PDF)

172P Gene expression in early breast cancer (EBC) patients (pts) with relapse despite pathologic complete response (pCR): An intra- and interindividual (matched control) analysis

Annals of oncology, 2020-09, Vol.31, p.S311-S311

2020

Volltextzugriff (PDF)

185P Safety, tolerability, and antitumor activity of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ metastatic breast cancer (mBC) and active brain metastases (BM) in DESTINY-Breast07 (DB-07)

ESMO open, 2024-05, Vol.9, p.103207, Article 103207

2024

Volltextzugriff (PDF)

1993 Sexually transmitted diseases treatment guidelines. Symposium

Clinical infectious diseases, 1995, Vol.20

1995

Volltextzugriff (PDF)

1O KEYNOTE-522 Asian subgroup: Phase III study of neoadjuvant pembrolizumab (pembro) vs placebo (pbo) + chemotherapy (chemo) followed by adjuvant pembro vs pbo for early triple-negative breast cancer (TNBC)

Annals of oncology, 2020-11, Vol.31, p.S1241-S1242

2020

Volltextzugriff (PDF)

A 2-mum CMOS 8-MIPS digital processor with parallel processing capability

IEEE journal of solid-state circuits, 1986-10, Vol.21 (5), p.750-765

1986

Volltextzugriff (PDF)

A 2-μm-CMOS 8-MIPS digital signal processor with parallel processing capability

IEEE journal of solid-state circuits, 1986-10, Vol.21 (5), p.750-765

1986

Volltextzugriff (PDF)

A 2-υm CMOS 10-MHz microprogrammable signal processing core with an on-chip multiport memory bank

IEEE journal of solid-state circuits, 1985, Vol.20 (3), p.754-760

1985

Volltextzugriff (PDF)

1 – 25 von 3.686

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.016)
Mit Volltextzugriff
(3.099)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.074)
Life Sciences & Biomedicine
(1.318)
Humans
(1.099)
Male
(685)
Female
(649)
Physical Sciences
(586)
Biological And Medical Sciences
(567)
Adult
(491)
Middle Aged
(468)
Physics
(434)
Medical Sciences
(412)
Technology
(339)
Infectious Diseases
(304)
Aged
(290)
Animals
(286)
Immunology
(255)
Fundamental And Applied Biological Sciences. Psychology
(210)
Exact Sciences And Technology
(201)
Hiv
(180)
Cohort Studies
(170)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.478)
Ingenta
(1.393)
MEDLINE
(1.378)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(1.010)
Publisher or Other Site
(690)
Access via ScienceDirect (Elsevier)
(618)
IngentaConnect Journals
(520)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(505)
Wiley-Blackwell Journals
(492)
Springer journals
(422)
Wiley Online Library
(356)
eBooks on EBSCOhost
(355)
Ebook Central Perpetual and DDA
(316)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(252)
Oxford Journals
(202)
JSTOR
(186)
Oxford Journals 2020 Medicine
(174)
IEEE/IET Electronic Library (IEL)
(116)
Thieme Connect
(113)
American Physical Society Journals
(78)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

1 MW, 140 GHz, CW gyrotron for Wendelstein 7-X

10‐year follow‐up after interferon‐α therapy for chronic hepatitis C

1037 POSTER The Prolyl-3-hydroxylases (P3H) and P3H-related Genes CRTAP and SC65 Are Novel Transcriptionally Silenced Genes in Burkitt's Lymphoma

1144P Clinical outcomes of NSCLC patients (pts) who had brain-only metastasis at time of stage IV diagnosis, by presence versus absence of EGFR/ALK mutations

1217P Breathomics eNose technology as a non-invasive, inexpensive, point-of-care predictive test to detect early stage lung cancer in never or former light smokers

1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types

123MO BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer

1243P Cumulative incidence and metastatic patterns of relapsed vs de novo stage IV non-small cell lung cancer (NSCLC) characterized by histology and EGFR status

1350P Characteristics, treatment patterns and outcome of non-small cell lung cancer (NSCLC) patients presenting with brain-only metastatic disease

1356P Cumulative incidence and baseline imaging patterns of brain metastases in advanced EGFR and ALK positive non-small cell lung cancer (NSCLC)

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

136TiP IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC

140 GHz, 1 MW, CW gyrotron for fusion plasma heating

140 GHz high-power gyrotron development for the stellarator W7-X

140GHz high-power gyrotron development for the stellarator W7-X

141P Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple negative breast cancer

164O Health-related quality of life (HRQoL) with pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as 1L treatment for advanced triple-negative breast cancer (TNBC): Results from KEYNOTE-355

1675P - Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain

172P Gene expression in early breast cancer (EBC) patients (pts) with relapse despite pathologic complete response (pCR): An intra- and interindividual (matched control) analysis

185P Safety, tolerability, and antitumor activity of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ metastatic breast cancer (mBC) and active brain metastases (BM) in DESTINY-Breast07 (DB-07)

1993 Sexually transmitted diseases treatment guidelines. Symposium

1O KEYNOTE-522 Asian subgroup: Phase III study of neoadjuvant pembrolizumab (pembro) vs placebo (pbo) + chemotherapy (chemo) followed by adjuvant pembro vs pbo for early triple-negative breast cancer (TNBC)

A 2-mum CMOS 8-MIPS digital processor with parallel processing capability

A 2-μm-CMOS 8-MIPS digital signal processor with parallel processing capability

A 2-υm CMOS 10-MHz microprogrammable signal processing core with an on-chip multiport memory bank

Suchergebnisse filtern